{"url_path":"/sec/advb/10-q/2026/item-5","section_key":"item-5","section_title":"Item 5 Other Information**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1941029/0001213900-26-057226-index.html","accession_number":"0001213900-26-057226","cik":"0001941029","ticker":"ADVB","issuer_name":"Advanced Biomed Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1941029/0001213900-26-057226-index.html","primary_entity_key":"0001941029","primary_entity_name":"Advanced Biomed Inc."},"word_count":28,"has_tables":true,"body_markdown":"**Item 5. Other Information**\n\n \n\nNo director or officer adopted\nor terminated any Rule 10b5-1 plan or any non-Rule 10b5-1 trading arrangement during the quarter ended March 31, 2026."}